KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $2.8 billion.

  • Eli Lilly's Long-Term Investments fell 1287.31% to $2.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year decrease of 1287.31%. This contributed to the annual value of $2.8 billion for FY2025, which is 1287.31% down from last year.
  • Eli Lilly's Long-Term Investments amounted to $2.8 billion in Q4 2025, which was down 1287.31% from $2.8 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Long-Term Investments registered a high of $3.5 billion during Q2 2021, and its lowest value of $2.6 billion during Q3 2022.
  • For the 5-year period, Eli Lilly's Long-Term Investments averaged around $3.0 billion, with its median value being $3.0 billion (2022).
  • Per our database at Business Quant, Eli Lilly's Long-Term Investments soared by 5043.51% in 2021 and then crashed by 2554.61% in 2022.
  • Eli Lilly's Long-Term Investments (Quarter) stood at $3.2 billion in 2021, then dropped by 9.67% to $2.9 billion in 2022, then increased by 5.18% to $3.1 billion in 2023, then increased by 5.37% to $3.2 billion in 2024, then dropped by 12.87% to $2.8 billion in 2025.
  • Its Long-Term Investments stands at $2.8 billion for Q4 2025, versus $2.8 billion for Q3 2025 and $3.2 billion for Q2 2025.